Keywords: |
adult; clinical article; treatment outcome; aged; middle aged; overall survival; salvage therapy; follow up; letter; neoplasm; neoplasms; biological marker; interleukin 2; neutrophil count; etoposide; hemoglobin; steroid; monoclonal antibody; alanine aminotransferase; aspartate aminotransferase; bilirubin; cytokine; antibodies, monoclonal; hematologic malignancy; gamma interferon; bone marrow biopsy; diagnosis; sepsis; natural killer cell; lactate dehydrogenase; pancytopenia; virus load; blood cell count; liver function test; drug therapy; blood clotting disorder; cytomegalovirus; epstein barr virus; alemtuzumab; lymphocyte count; ferritin; platelet count; erythrophagocytosis; hemophagocytic syndrome; lymphohistiocytosis, hemophagocytic; cxcl9 chemokine; etiology; complication; neutralizing antibody; antibodies, neutralizing; humans; human; male; female; positron emission tomography-computed tomography; emapalumab
|